Sex: F
Vaccine: PPV
Symptoms: Injection site pain, Rash, Urticaria
Clinical narrative: after being administered the PNEUMOVAX 23 she had a "very bad reaction"; very bad reaction / reactions as severe hives and itching; Tongue swelling; Hives on both arms, stomach and both legs / very bad reaction / reactions as severe hives and itching; A rash; Pain at the injection site; Information has been received from a 71-year-old female retired nurse, who was also the patient. The patient's concurrent conditions were not reported. Her drug reactions/allergies included shellfish, penicillin, cefazolin (ANCEF), ceftriaxone (ROCEPHIN), ciprofloxacin (CIPRO), vancomycin, other antibiotics unspecified, morphine, hydromorphone hydrochloride (DILAUDID) and iodine. Concomitant therapies included calcium carbonate (+) cholecalciferol (+) phytonadione (VIACTIV SOFT CALCIUM CHEWS), vitamin D (unspecified) and aspirin.  On 01-OCT-2009, she was vaccinated subcutaneously with a single dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) as prophylaxis.   The nurse reported that she received pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) and experienced a rash and hives on both arms, stomach and both legs and pain at the injection site. On 04-OCT-2009 the patient recovered from all symptoms. The patient sought medical attention (office visit). No laboratory diagnostics studies were performed.  Follow up information has been received from the physician, on 11-JAN-2010. It was reported that the patient had a significant allergy to iodine and all antibiotics except erythromycin. On 01-OCT-2009 the patient was vaccinated intramuscularly in the right deltoid with a dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23). The patient experienced urticaria and recovered on 03-OCT-2009.  Follow-up information was received from the nurse (patient), on 11-JUN-2020.  On an unspecified date (also reported as"within the past 6 years", and previously reported as 01-OCT-2009 (conflicting information)), the patient was vaccinated with a dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (dose, route of administration, vaccination scheme and anatomical site of vaccination were unknown by reporter; lot number and expiration date were not reported) as prophylaxis, also reported as ("routine vaccine").  On an unknown date (reported as 15 hours later), after pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) vaccination, the patient experienced a very bad reaction (adverse reaction), her tongue swelled up (swollen tongue), and she developed severe hives and itching (urticaria and pruritus). Additionally, the patient sought medical attention, and contacted the physician, she received steroids as treatment for the events.  At the time of the report, the events had resolved.  The causal relationship between pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) and the aforementioned events was not provided.  It has been determined that case # US-009507513-2006USA004737 is a duplicate of case # US-009507513-0910USA03578. Therefore, case # US-009507513-2006USA004737 is being deleted from our files and the cases are consolidated into case # US-009507513-0910USA03578.